Janux Therapeutics Overview
Janux Therapeutics Target Price
Analysts' 12-month price predictions for JANX.
Get informed when a big investor buys or sells
+ FollowShare Price
$15.78
Average Target Price
$22.60
43.2% upside
43.2% upside5 analysts in the last 4 months
High: $36 | Low: $14
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-25 | Truist Financial | $26 | 64.8% upside |  |
| 2026-05-11 | Evercore ISI | $22 | 39.4% upside | |
| 2026-05-08 | Wedbush | $36 | 128.1% upside | |
| 2026-04-20 | BarclaysEtzer Darout | $14 |  11.3% downside | |
| 2026-04-15 | UBS | $15 | 4.9% downside | |
| 2026-01-16 | Piper SandlerKelsey Goodwin | $30 | 90.1% upside | |
| 2025-12-17 | Barclays | $29 | 83.8% upside | |
| 2025-12-02 | UBSDavid Dai | $57 | 261.2% upside | |
| 2025-12-02 | Stifel NicolausStephen Willey | $38 | 140.8% upside | |
| 2025-12-02 | H.C. Wainwright | $45 | 185.2% upside | |
| 2025-09-16 | Barclays | $47 | 197.8% upside | |
| 2025-09-10 | Stifel Nicolaus | $45 | 185.2% upside | |
| 2025-09-03 | GuggenheimBrad Canino | $72 | 356.3% upside | |
| 2025-07-11 | Raymond JamesSean McCutcheon | $65 | 311.9% upside | |
| 2025-02-28 | Scotiabank | $41 | 159.8% upside | |
| 2025-02-28 | Wedbush | $76 | 381.6% upside | |
| 2024-12-03 | BTIGJustin Zelin | $100 | 533.7% upside | |
| 2024-10-24 | UBSDavid Dai | $69 | 337.3% upside | |
| 2024-09-05 | Stifel NicolausBradley Canino | $70 | 343.6% upside | |
| 2024-08-09 | ScotiabankGeorge Farmer | $42 | 166.2% upside | |
| 2024-05-30 | ScotiabankGeorge Farmer | $47 | 197.8% upside | |
| 2024-05-13 | H.C. WainwrightSwayampakula Ramakanth | $63 | 299.2% upside | |
| 2024-03-20 | BTIGKaveri Pohlman | $62 | 292.9% upside | |